Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Vaccine-Related Journal Articles

Diseases and Vaccines: Haemophilus influenzae type b (Hib)
Hib archive 2003-1991
Haemophilus influenzae type b (Hib) 2012
National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months--United States, 2011
Source: MMWR, September 7, 2012, Vol. 61(35):689-96
HTML
Haemophilus influenzae Type b Disease and Vaccine Booster Dose Deferral, United States, 1998-2009
Authors: Briere EC, Jackson M, Shah SG, et al.
Source: Pediatrics, September 2012, Vol. 130(3):414-20
Abstract
back to top
Haemophilus influenzae type b (Hib) 2011
National and State Vaccination Coverage among Children Aged 19-35 Months--United States, 2010
Source: MMWR, September 2, 2011, Vol. 60(34):1157-63
HTML
County-Level Trends in Vaccination Coverage among Children Aged 19-35 Months--United States, 1995-2008
Source: MMWR, April 29, 2011, Vol. 60(SS-04):1-86
HTML
Up-to-Date Haemophilus Influenzae type b Vaccination Coverage during a Vaccine Shortage
Authors: White KE, Pabst LJ, Cullen KA
Source: Pediatrics, March 2011, Vol. 127(3):e707-12
HTML
back to top
Haemophilus influenzae type b (Hib) 2010
National, State, and Local Area Vaccination Coverage among Children Aged 19--35 Months--United States, 2009
Source: MMWR, September 17, 2010, Vol. 59(36):1171-7
HTML
Changes in Measurement of Haemophilus influenzae serotype b (Hib) Vaccination Coverage--National Immunization Survey, United States, 2009
Source: MMWR, August 27, 2010, Vol. 59(33):1069-72
Abstract
Changing Epidemiology of Invasive Haemophilus influenzae in Ontario, Canada: Evidence for Herd Effects and Strain Replacement Due to Hib Vaccination
Authors: Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN
Source: Vaccine, April 14, 2010
Abstract
back to top
Haemophilus influenzae type b (Hib) 2009
Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine
Source: MMWR, September 18, 2009, Vol. 58(36):1008-9
HTML | PDF (entire issue)
Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America
Authors: Pickering LK, Baker CJ, Freed GL, et al.
Source: Clin Infect Dis, September 15, 2009, Vol. 49(6):817-40
Abstract
National, State, and Local Area Vaccination Coverage among Children Aged 19-35 Months--United States, 2008
Source: MMWR, August 28, 2009, Vol. 58(33):921-6
HTML
Updated Recommendations for Use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12 -15 Months
Source: MMWR, June 26, 2009, Vol. 58(24):673-4
HTML | PDF (entire issue)
Trends in Early Childhood Vaccination Coverage: Progress towards US Healthy People 2010 Goals
Authors: Zhao Z, Smith PJ, Luman ET
Source: Vaccine, June 12, 2009
Abstract
Invasive Haemophilus influenzae Type B Disease in Five Young Children--Minnesota, 2008
Source: MMWR, January 30, 2009, Vol. 58(03):58-60
HTML | PDF (entire issue)
back to top
Haemophilus influenzae type b (Hib) 2008
Continued Shortage of Haemophilus influenzae type b (Hib) Conjugate Vaccines and Potential Implications for Hib Surveillance--United States, 2008
Author: Centers for Disease Control and Prevention
Source: MMWR, November 21, 2008, Vol. 57(46):1252-55
HTML | PDF (entire issue)
Ongoing Control of Haemophilus influenzae type B Infections in Canadian Children, 2004-2007
Authors: Scheifele DW, Bettinger JA, Halperin SA, Law B, Bortolussi R
Source: Pediatr Infect Dis J, August 2008, Vol. 27(8):755-7
Abstract
Haemophilus influenzae type b Conjugate Vaccine Use and Effectiveness
Authors: Morris SK, Moss WJ, Halsey N
Source: Lancet Infect Dis, July 2008, Vol. 8(7):435-43
Abstract
The Impact of Vaccines on Pneumonia: Key Lessons from Haemophilus influenzae type b Conjugate Vaccines
Authors: Gessner BD, Adegbola RA
Source: Vaccine, June 16, 2008, Vol. 26 Suppl 2:B3-8
Abstract
Invasive Pneumococcal Disease in Children 5 Years after Conjugate Vaccine Introduction--Eight States, 1998-2005
Author: Centers for Disease Control and Prevention
Source: MMWR, February 15, 2008, Vol. 57(06):144-8
HTML | PDF (entire issue)
Progress toward Introduction of Haemophilus influenzae type b Vaccine in Low-Income Countries--Worldwide, 2004-2007
Author: Centers for Disease Control and Prevention
Source: MMWR, February 15, 2008, Vol. 57(06):148-151
HTML | PDF (entire issue)
Interim Recommendations for the Use of Haemophilus influenzae type b (Hib) Conjugate Vaccines Related to the Recall of Certain Lots of Hib-Containing Vaccines (PedvaxHIB and Comvax)
Author: Centers for Disease Control and Prevention
Source: MMWR, December 21, 2007, Vol. 56(50):1318-20
HTML | PDF (entire issue)
Diphtheria, Pertussis, Poliomyelitis, Tetanus, and Haemophilus influenzae Type b Vaccinations and Risk of Eczema and Recurrent Wheeze in the First Year of Life
Authors: Kummeling I, Thijs C, Stelma F, et al
Source: Pediatrics, February 2007; 119:367-373
Abstract
General Recommendations on Immunization
Source: MMWR, December 1, 2006; 55(RR-15):1-48
HTML |  PDF (entire issue)
Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine Introduction into Routine Childhood Immunization in Kenya
Authors: Cowgill KD, Ndiritu M, Nyiro J, et al
Source: JAMA, August 9, 2006, Vol. 296(6):671-678
Abstract
Epiglottitis in the Hemophilus Influenzae Type B Vaccine Era: Changing Trends
Authors: Shah RK, Roberson DW, Jones DT
Source: Laryngoscope, March 2004, Vol. 114(3):557-560
Abstract
Post-Marketing Evaluation of the Short Term Safety of COMVAX
Authors: Davis RL, Black S, Shinefield H, et al
Source: Vaccine, January 2, 2004, Vol. 22(3-4):536-543
Abstract
Impact of Routine Vaccination with a Conjugate Haemophilus Influenzae Type B Vaccine
Authors: Hviid A, Melbye M
Source: Vaccine, January 2, 2004, Vol. 22(3-4):378-382
Abstract
back to top
Haemophilus influenzae type b (Hib) Archive
Hib journal articles 2003-1991
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.